Coarctation of the Aorta (CoA): Causes, Symptoms, Diagnosis and Treatment — Overview, Diagnosis & Treatment Options | MyMedicPlus

Coarctation of the aorta (CoA) is one of the most common congenital cardiovascular defects, characterized by narrowing of the aorta — most frequently at the aortic isthmus, just distal to the left subclavian artery and adjacent to the ligamentum arteriosum. It occurs in approximately 1 in 2,500 live births and accounts for 5-8% of all congenital heart disease. The hemodynamic consequence of CoA is upper body hypertension (from obstructed proximal aortic flow) and reduced lower body perfusion (from downstream pressure loss). CoA presents across a clinical spectrum: critical duct-dependent neonatal presentation requiring immediate prostaglandin E1 treatment, childhood presentation with incidental hypertension, or adult discovery of treatment-resistant hypertension. Bicuspid aortic valve co-exists in 50-85% of patients. Without treatment, unrepaired severe CoA carries a median survival of only 35 years, primarily from hypertension complications (stroke, aortic dissection, heart failure, coronary artery disease). Modern surgical and catheter-based repair techniques have transformed prognosis — though lifelong cardiology surveillance remains essential due to residual hypertension, aortic aneurysm risk, and bicuspid aortic valve progression.

Two main developmental theories explain CoA pathogenesis: the ductal tissue hypothesis — ectopic ductal smooth muscle that extends into the adjacent aortic wall constricts when the ductus arteriosus normally closes after birth, producing the classic juxtaductal narrowing; and the hemodynamic theory — reduced left-sided cardiac output in utero (due to co-existing intracardiac defects) results in underdevelopment of the aortic arch. Turner syndrome (45,X chromosomal monosomy) is the strongest individual genetic risk factor: 30-35% of Turner syndrome females have CoA, and 10-15% of females with CoA have Turner syndrome. NKX2.5, GATA4, NOTCH1, and ELN gene mutations have been identified in sporadic CoA families. Associated congenital defects: bicuspid aortic valve (50-85%), ventricular septal defect (30%), subaortic stenosis, hypoplastic left heart syndrome, transposition of the great arteries. Male sex predominates (2:1 male-to-female ratio). Familial recurrence risk is approximately 2-4% in siblings.

Neonatal presentation: severe CoA with duct-dependent systemic circulation presents in the first week of life with sudden cardiovascular collapse when the ductus arteriosus closes — poor feeding, tachypnea, pallor, absent femoral pulses, and metabolic acidosis requiring emergency prostaglandin E1 infusion. Childhood presentation: milder CoA presents with upper limb hypertension causing headaches and nosebleeds; discrepancy between arm and leg blood pressure (more than 20 mmHg difference); diminished femoral pulses with radiofemoral delay; and a systolic ejection murmur heard in the left back/interscapular area. Adult presentation: treatment-resistant upper limb hypertension; cold lower extremities; leg claudication on exertion; headache and palpitations from hypertension; CXR showing rib notching (from enlarged intercostal collateral arteries) and the '3 sign' (pre- and post-stenotic aortic dilation). Aortic dissection, intracranial aneurysm rupture, and premature coronary artery disease are major complications of unrepaired adult CoA.

Four-limb blood pressure measurement: systolic BP difference greater than 20 mmHg between right arm and lower limb(s) with diminished femoral pulses is the clinical hallmark of significant CoA. Echocardiography: identifies the coarctation site, estimates Doppler gradient, assesses left ventricular function, and detects associated defects including bicuspid aortic valve and VSD. Cardiac MRI (preferred in adolescents and adults): provides precise anatomical characterization of the coarctation, aortic arch dimensions, collateral flow, and associated aortic pathology without ionizing radiation — the gold standard for pre-intervention planning and post-repair surveillance. CT aortography: used when MRI is contraindicated; excellent for aortic anatomy and intervention planning. Cardiac catheterization: peak-to-peak gradient of 20 mmHg or greater across the coarctation is the threshold for intervention per AHA/ACC 2018 guidelines; simultaneous intervention may be performed. Genetic testing (karyotype) should be performed in all female patients to exclude Turner syndrome.

Neonatal and infant management: prostaglandin E1 (alprostadil) IV infusion immediately to maintain ductal patency and stabilize hemodynamics pending definitive repair. Neonates and infants (under 15 kg): surgical repair by extended end-to-end anastomosis (resection of the coarctation segment with primary anastomosis using native tissue) is the gold standard — low operative mortality at specialist centers. Subclavian flap aortoplasty and Dacron patch repair are no longer first-line due to late aneurysm risk. Older children (over 25 kg), adolescents, and adults: catheter-based balloon dilation with covered stent implantation (Cheatham-Platinum or AndraStent) is preferred per AHA/ACC 2018 guidelines for native discrete CoA and re-coarctation after prior surgery — comparable outcomes to surgery with less invasiveness. Post-repair care: antihypertensive therapy (ACE inhibitors, ARBs, beta-blockers) for persistent hypertension; infective endocarditis prophylaxis for 6 months post-intervention. Annual echocardiography with 4-limb BP monitoring; MRI or CT aortography every 5 years for surveillance of the repair site, aortic dimensions, and bicuspid aortic valve progression.

Prognosis after successful CoA repair has improved markedly with modern techniques, but lifelong cardiovascular vigilance remains essential. Operative mortality for neonatal CoA repair at experienced pediatric cardiac surgery centers is less than 5% for isolated CoA and less than 10% with complex associated defects. Long-term survival after repair is significantly better than natural history — untreated severe CoA carries median survival of only approximately 35 years, with nearly 90% mortality by age 50 from hypertension complications. After successful repair, 20-year actuarial survival exceeds 85%; however, CoA patients retain a 2-5-fold higher cardiovascular risk than the general population throughout their lives. Persistent or recurrent hypertension — occurring in 30-40% of patients repaired after childhood — remains the primary modifiable risk factor driving long-term cardiovascular outcomes including aortic dissection, stroke, heart failure, and premature coronary artery disease. Aortic aneurysm formation at the repair site occurs in 5-15% of patients repaired with patch techniques and requires surveillance imaging for early detection before dissection risk develops. Bicuspid aortic valve disease, present in 50-85% of CoA patients, often progresses to aortic stenosis or regurgitation requiring valve intervention in the fourth to sixth decade of life, contributing to long-term cardiovascular morbidity. Re-coarctation requiring intervention develops in approximately 5-10% of surgically repaired patients over 20 years. Key prognostic factors include age and technique at initial repair, adequacy of long-term blood pressure control, presence and severity of bicuspid aortic valve disease, and aortic dimensions at the repair site. AHA/ACC 2018 guidelines mandate lifelong cardiology follow-up with annual clinical assessment and 4-limb BP measurement, echocardiography every 3-5 years, and MRI or CT aortography every 5 years.

Coarctation of the aorta is a congenital structural defect that cannot be prevented by any known lifestyle or environmental measure. Prenatal cardiac screening: fetal echocardiography at 18-22 weeks identifies major structural cardiac defects including CoA, enabling planned delivery at a center with neonatal cardiac surgery capability and eliminating the risk of undiagnosed CoA presenting with life-threatening neonatal cardiovascular collapse. Fetal echo is recommended in pregnancies with family history of congenital heart disease, maternal diabetes, chromosomal anomalies (Turner syndrome, trisomy 18), or first-trimester exposure to teratogenic drugs. Girls with Turner syndrome identified prenatally or postnatally require immediate cardiac evaluation — cardiac MRI or echocardiography detects CoA before symptoms develop. Post-repair secondary prevention: optimal blood pressure control (target below 130/80 mmHg), smoking cessation, cholesterol management, and regular physical activity substantially reduce the excess cardiovascular risk that CoA patients carry even after successful anatomical repair. Pregnancy planning with pre-conception cardiology consultation prevents maternal cardiovascular complications.

Emergency evaluation is required for: any neonate in the first week of life with sudden cardiovascular deterioration, absent femoral pulses, poor perfusion, or hemodynamic collapse — undiagnosed CoA with closing ductus is a time-critical cardiac emergency. In older children and adults, see a cardiologist promptly for: unexplained upper limb hypertension especially in young individuals under 35 years; blood pressure that does not respond to two or more antihypertensive agents; arm-to-leg blood pressure difference exceeding 20 mmHg on routine measurement; a murmur heard in the interscapular region; or coarctation found incidentally on chest imaging. Established CoA patients — repaired and unrepaired — must maintain annual cardiology follow-up regardless of symptoms, as complications including aortic aneurysm, dissection, and progressive bicuspid aortic valve disease may develop silently. Women with CoA who are pregnant or planning pregnancy need specialist congenital heart disease obstetrics review — increased risk of maternal aortic dissection during labor and delivery requires delivery planning at a specialist center with cardiac surgical backup.